BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 12338631)

  • 1. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observations on LRH-A used for contraception by luteolysis in normal women--analysis of 88 cases].
    Lu RK; Chen HY; Liu Y; Zhang L; He YJ; Ge LJ; Yuan XW; Qui XD
    Shengzhi Yu Biyun; 1987; 7(1):39-40, 45-7. PubMed ID: 12341309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New contraceptives tested for women and men.
    Stephenson G
    Res Resour Rep; 1983 May; 7(5):1-4. PubMed ID: 12338626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
    Schally AV
    Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
    Doyen J; Schaaps JP; Lambotte R
    Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-coital contraception].
    Serfaty D
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H; Jung C; Taubert HD
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone-releasing hormone (LHRH) and its analogs for contraception in women: a review.
    Thau RB
    Contraception; 1984 Feb; 29(2):143-62. PubMed ID: 6426857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of fertility by anti-hCG vaccines].
    Frydman R; Bellet D
    Contracept Fertil Sex (Paris); 1987 Sep; 15(9):817-20. PubMed ID: 12281242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for male contraception. Men are different.
    Steinmann M
    RF Illus; 1982 Jun; ():29-31. PubMed ID: 12264477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolysis in humans and subhuman primates.
    Henzl MR
    Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
    Lemay A; Labrie F; Raynaud JP
    Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-cycle contraception with LHRH in women.
    Maia H; Barbosa IC; Maia H; Coutinho EM
    Reproduccion; 1981; 5(4):251-60. PubMed ID: 7033017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.